Detection of loss of heterozygosity at RAD51, RAD52, RAD54 and BRCA1 and BRCA2 loci in breast cancer: pathological correlations
1999

Loss of Genetic Variability in Breast Cancer

Sample size: 127 publication Evidence: moderate

Author Information

Author(s): Gonzalez R, Silva J M, Dominguez G, Garcia J M, Martinez G, Vargas J, Provencio M, EspaƱa P, Bonilla F

Primary Institution: Clinica Puerta de Hierro, Madrid, Spain

Hypothesis

Does loss of heterozygosity at specific genetic loci correlate with pathological parameters in breast cancer?

Conclusion

The study found significant correlations between loss of heterozygosity at certain genetic loci and various pathological parameters in breast cancer.

Supporting Evidence

  • LOH was found in the RAD51 region in 32% of tumors.
  • LOH was found in the RAD52 region in 16% of tumors.
  • LOH was found in the RAD54 region in 20% of tumors.
  • LOH was found in the BRCA1 region in 49% of tumors.
  • LOH was found in the BRCA2 region in 44% of tumors.
  • Significant correlations were observed with respect to age, estrogen receptor content, progesterone receptors, higher grade, more advanced stage, and peritumoral vessel involvement.

Takeaway

The study looked at how certain genes related to breast cancer might be missing parts, and this could mean the cancer is worse.

Methodology

The study analyzed DNA from breast cancer tumors for loss of heterozygosity using PCR and 15 genetic markers.

Participant Demographics

The study included breast cancer patients, with a notable observation of three patients under 30 years old having loss of heterozygosity at five regions.

Statistical Information

P-Value

0.001, 0.003, 0.004, 0.008, 0.03, p<0.0001

Statistical Significance

p<0.0001

Digital Object Identifier (DOI)

10.1038/sj.bjc.6690722

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication